ARYDX | MGLKX | ARYDX / MGLKX | |
Total Expense Ratio | 0.77 | 1.44 | 53% |
Annual Report Gross Expense Ratio | 0.77 | 1.45 | 53% |
Fund Existence | 12 years | 11 years | - |
Gain YTD | 4.022 | 3.290 | 122% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 858M | 2.22B | 39% |
Annual Yield % from dividends | 2.44 | 1.86 | 131% |
Returns for 1 year | 8.23 | 1.89 | 435% |
Returns for 3 years | 15.09 | -4.92 | -307% |
Returns for 5 years | 30.21 | 12.12 | 249% |
Returns for 10 years | 54.90 | 17.16 | 320% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
VYMYX | 20.05 | 0.16 | +0.80% |
Voya Mid Cap Research Enhanced Index W | |||
OTCNX | 78.78 | 0.47 | +0.60% |
Invesco Discovery Large Cap R | |||
GGFRX | 15.02 | 0.07 | +0.47% |
Nationwide BNY Mellon Dyn US Core R | |||
GCVAX | 24.55 | 0.07 | +0.29% |
Goldman Sachs Large Cp Val Insghts A | |||
LHCOX | 18.64 | 0.05 | +0.27% |
Lord Abbett Health Care F3 |